Mummy remains refute antiquity of ankylosing spondylitis

No signs of disabling spinal arthritis in Egyptian mummies

2014-10-20

(Press-News.org) Ankylosing spondylitis is a systemic disease that causes inflammation in the spinal joints and was thought to have affected members of the ancient Egyptian royal families. Now a new study published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), refutes that claim, finding instead a degenerative spinal condition called diffuse idiopathic skeletal hyperostosis (DISH) in royal Egyptian mummies from the 18th to early 20th Dynasties.

Ankylosing spondylitis is a member of a group of inflammatory conditions called the spondyloarthropathies that cause arthritis and affect up to 2.4 million Americans over the age of 15 according to the ACR. The most common in this rheumatic disease family is ankylosing spondylitis, which causes pain and stiffness in the back, and may lead to bony fusion of the spine. Studies estimate that ankylosing spondylitis affects about one percent of the population, primarily affecting young men.

In DISH the hardening of ligaments along the vertebrae of the spine cause stiffness in the upper back and can affect other joints in the body. While DISH may appear similar to ankylosing spondylitis, it is a degenerative and not an inflammatory type of arthritis, affecting those 60 years of age and older.

Previous research using x-ray images claimed that three Pharaohs (Amenhotep II, Ramesses II, and his son Merenptah) displayed evidence of ankylosing spondylitis. The current study used computed tomography (CT), a more sophisticated imaging technology, to study thirteen royal Egyptian mummies from 1492-1153 BC to determine if signs of ankylosing spondylitis or DISH were present.

A diagnosis of ankylosing spondylitis was ruled out due to the absence of joint erosion in the lower back and pelvis area (sacroiliac joints) or fusion of sacroiliac joints or of small joints between the vertebra in the spine (facet joints) on the CT scans of the mummies. Signs of DISH were found in four Pharaohs (Amenhotep III—18th Dynasty; Ramesses II, his son Merenptah, and Ramesses III—19th to early 20th Dynasties).

The study was conducted by Dr. Sahar Saleem with the Kasr Al Ainy Faculty of Medicine in Cairo, Egypt and Dr. Zahi Hawass, Egyptologist and former head of the Egyptian Supreme Council of Antiquities. The authors say, "The mummies of Ancient Egypt offer a wealth of information regarding the history of disease. In studying these ancient remains we may be able to uncover the pathway of diseases—like ankylosing spondylitis or DISH—and how they might impact modern populations." Dr. Sahar Saleem adds, "The process of mummification could induce spinal changes, which should be considered when investigating diseases in ancient remains."

INFORMATION: This study is published in Arthritis & Rheumatology. Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com.

Full citation: "Ankylosing Spondylitis or Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Royal Egyptian Mummies of 18th-20th Dynasties? CT and Archaeology Studies." Sahar N Saleem and Zahi Hawass. Arthritis & Rheumatology; Published Online: October 20, 2014 (DOI: 10.1002/art.38864).

URL Upon Publication: http://doi.wiley.com/10.1002/art.38864

Media Advisory 2014 ACR/ARHP Annual Meeting Press Registration Now Open.

What: Registration is now open to journalists planning to attend the 2014 ACR/ARHP Annual Meeting in Boston. Thousands of rheumatologists and rheumatology health professionals are expected to attend this year's meeting, which will highlight the latest advances in rheumatology research.

Where: Boston Convention Center; Boston, Mass. .

When: November 15-19, 2014

Online Registration: To register for a press badge click here Policies: Please make sure to review our press guidelines http://www.acrannualmeeting.org/Press as they may impact your ability to receive press credentials Dates for this year's annual meeting: Press registration closes: Monday, November 3 Press conference schedule announced: Early-October On-site Newsroom opens: Saturday, November 15; 7:30 AM ET Opening Lecture/Embargo lifts: Saturday, November 15; 4:30 PM ET

http://www.acrannualmeeting.org/Press or contact Bonny Senkbeil at (404) 633-3777 or via e-mail at bsenkbeil@rheumatology.org, 404-633-3777

About the Journal Arthritis & Rheumatology is an official journal of the American College of Rheumatology (ACR) and covers all aspects of inflammatory disease. The American College of Rheumatology (http://www.rheumatology.org) is the professional organization whose members share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. The journal is published by Wiley on behalf of the ACR. For more information, please visit http://wileyonlinelibrary.com/journal/art.

About Wiley Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.

Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025

2014-10-20

CHICAGO, OCTOBER 20, 2014 – The U.S. Government has initiated a major effort to prevent and effectively treat Alzheimer's disease by 2025. However, a workgroup of nearly 40 Alzheimer's researchers and scientists says the research milestones in the U.S. Government's National Plan to Address Alzheimer's Disease must be broadened in scope, increased in scale, and adequately funded in order to successfully achieve this goal. A series of proposals by the workgroup to enlarge and strengthen the Plan are published today in Alzheimer's & Dementia: the Journal of the Alzheimer's ...

Head injury causes the immune system to attack the brain

2014-10-20

Scientists have uncovered a surprising way to reduce the brain damage caused by head injuries - stopping the body's immune system from killing brain cells. The study, published in the open access journal Acta Neuropathologica Communications, showed that in experiments on mice, an immune-based treatment reduced the size of brain lesions. The authors suggest that if the findings apply to humans, this could help prevent brain damage from accidents, and protect players of contact sports like American football, rugby and boxing. To date, there are no effective treatments to ...

Viagra protects the heart beyond the bedroom

2014-10-20

Viagra could be used as a safe treatment for heart disease, finds new research published today in the open access journal BMC Medicine. The study reveals that long-term daily treatment of Viagra can provide protection for the heart at different stages of heart disease, with few side effects. Phosphodiesterase-5 inhibitor (PDE5i) is the main ingredient in Viagra and other drugs commonly used to treat erectile dysfunction. The inhibitor blocks the enzyme PDE5, which prevents relaxation of smooth muscle tissue. The presence of PDE5 in the heart has led to previous research ...

Group B streptococcus incidence rises significantly among newborns

2014-10-20

The findings suggest that this disturbing trend could be due the emergence of more virulent group B streptococcal strains and call for a renewed evaluation of preventive strategies to reduce neonatal disease. Passed from mother to child during birth, group B streptococcus is the most common cause of infection in newborns. Guidelines for the prevention of disease have been widely adopted in high-income countries. But despite these efforts, the bacterium remains a leading cause of blood stream infections and meningitis worldwide, typically affecting babies younger than ...

Metabolic genetics research paves way to treating diabetes and obesity

2014-10-19

BETHESDA, MD – Breaking down complex conditions such as Type 2 Diabetes and obesity into the specific metabolic proteins and processes that underlie them offers a new approach to studying the genetics of these diseases and how they are interrelated, according to research presented today at the American Society of Human Genetics (ASHG) 2014 Annual Meeting in San Diego. By studying specific proteins that contribute to such conditions – and the genes that encode them – scientists can develop new drugs that directly target the metabolic processes that do ...

Improved electricity access has little impact on climate change

2014-10-19

Improving household electricity access in India over the last 30 years contributed only marginally to the nation's total carbon emissions growth during that time, according to a new study published in the journal Nature Climate Change. "Energy access is fundamental to development: it brings improvements to all aspects of life, including education, communication, and health," says IIASA researcher Shonali Pachauri, who conducted the study. While increased energy access is widely agreed to be an important goal for development efforts, such as the UN Sustainable Energy ...

Lab-developed intestinal organoids form mature human tissue in mice

2014-10-19

VIDEO: Michael Helmrath, M.D., M.S., surgical director of the Intestinal Rehabilitation Program at Cincinnati Children's Hospital Medical Center, talks about researchers successfully growing human intestinal tissue in mice. The study describes... Click here for more information. CINCINNATI --Researchers have successfully transplanted "organoids" of functioning human intestinal tissue grown from pluripotent stem cells in a lab dish into mice – creating an unprecedented ...

Crystallizing the DNA nanotechnology dream

2014-10-19

DNA has garnered attention for its potential as a programmable material platform that could spawn entire new and revolutionary nanodevices in computer science, microscopy, biology, and more. Researchers have been working to master the ability to coax DNA molecules to self assemble into the precise shapes and sizes needed in order to fully realize these nanotechnology dreams. For the last 20 years, scientists have tried to design large DNA crystals with precisely prescribed depth and complex features – a design quest just fulfilled by a team at Harvard's Wyss Institute ...

Imaging electric charge propagating along microbial nanowires

2014-10-19

AMHERST, Mass. ¬– The claim by microbiologist Derek Lovley and colleagues at the University of Massachusetts Amherst that the microbe Geobacter produces tiny electrical wires, called microbial nanowires, has been mired in controversy for a decade, but the researchers say a new collaborative study provides stronger evidence than ever to support their claims. UMass Amherst physicists working with Lovley and colleagues report in the current issue of Nature Nanotechnology that they've used a new imaging technique, electrostatic force microscopy (EFM), to resolve ...

I have anxiety, why is my doctor prescribing an antipsychotic?

2014-10-19

Berlin, 19th October 2014 What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment. Now in a significant shift, the world's major psychiatry organisations are proposing to completely change the terminology of the drugs used in mental disorders shifting it from symptom based (e.g. antidepressant, antipsychotic etc.) to pharmacologically based (e.g. focusing on pharmacological target (serotonin, dopamine etc.) and the relevant mode of action). This will mean that patient will no longer have ...

LAST 30 PRESS RELEASES:

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Mobile device location data is already used by private companies, so why not for studying human-wildlife interactions, scientists ask

Test reveals mice think like babies

[Press-News.org] Mummy remains refute antiquity of ankylosing spondylitis
No signs of disabling spinal arthritis in Egyptian mummies